EgyptResearch and clinical trials
87 children with Glanzmann thrombasthenia in Egypt: in more than half, the parents are related
A study published in a journal and reviewed by independent scientists. Even so, a single study is not conclusive; it needs to be replicated.
In Egypt, 87 children with Glanzmann thrombasthenia from several centers were studied. In 55% of the children, the mother and father were related to each other. The first symptom appeared at a median age of three. The most common first symptom was nosebleeds. Bleeding responded best to treatment containing a clotting factor.
What does it mean for patients and families?
This disease is more common in countries where marriage between relatives is frequent. For a child with frequent nosebleeds, bleeding tests can be discussed with a doctor. This is also a notable finding for Türkiye.
Source
Scientific paper: Glanzmann thrombasthenia: a multi-center study of demographics, clinical spectrum, and treatment efficacy. European Journal of Pediatrics, 2025. DOI: 10.1007/s00431-025-06126-4 · PubMed 40301132
The source page was opened and read on October 7, 2026. Summary prepared by the Doktorclub editorial team and translated from Turkish; it has not yet been reviewed by a physician (a scientific board is being set up).
This page is translated from the Turkish original.
Related disease: Glanzmann thrombasthenia
This page reports a development; it is not a treatment recommendation. Your doctor decides whether a treatment is right for you.